en

PRODUCT DETAIL

VITRAKVI 20 mg/ml perorálny roztok

Code 8504D
MA number EU/1/19/1385/004
Product Form: sol por 2x50 ml (fľ.skl.jantár.)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX12 Larotrectinib
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 19.09.2019
Validity: 23.09.2024
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 13.07.2023
eu-flag.png sk-flag.png